KIDS - OrthoPediatrics Corp.
NASDAQ
->
Healthcare
->
Medical Devices
Warsaw,
United States
Type: Equity
KIDS price evolution
KIDS
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $51.05 | $30.89 | $23.56 | $33.03 |
| Short term investments | $26.14 | $49.25 | ||
| Net receivables | $42.83 | $42.03 | $36.27 | $34.62 |
| Inventory | $120.93 | $116.37 | $112.69 | $105.85 |
| Total current assets | $248.31 | $193.78 | $203.72 | $226.5 |
| Long term investments | ||||
| Property, plant & equipment | $54.77 | $53.48 | $48.72 | $41.05 |
| Goodwill & intangible assets | $177.03 | $180.66 | $168.26 | |
| Total noncurrent assets | $236.98 | $233.46 | $212.25 | |
| Total investments | $26.14 | $49.25 | ||
| Total assets | $489.29 | $430.76 | $437.19 | $438.75 |
| Current liabilities | ||||
| Accounts payable | $11.65 | $17 | $19.74 | $12.65 |
| Deferred revenue | ||||
| Short long term debt | $1.46 | $10.52 | $10.3 | |
| Total current liabilities | $34.63 | $39.57 | $45.82 | $41.67 |
| Long term debt | $72.51 | $12.15 | $13.76 | $13.46 |
| Total noncurrent liabilities | $19.9 | $20.78 | $20.05 | |
| Total debt | $13.61 | $24.29 | $23.76 | |
| Total liabilities | $118.38 | $59.47 | $66.6 | $61.72 |
| Shareholders' equity | ||||
| Retained earnings | -$219.5 | -$211.58 | -$205.55 | -$197.74 |
| Other shareholder equity | -$6.6 | -$10.22 | -$6.96 | -$5.53 |
| Total shareholder equity | $371.29 | $370.58 | $377.02 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $33.03 | $8.99 | $9.01 | $30.13 |
| Short term investments | $49.25 | $109.3 | $45.9 | $55.48 |
| Net receivables | $34.62 | $24.8 | $17.94 | $17.21 |
| Inventory | $105.85 | $78.19 | $57.57 | $52.99 |
| Total current assets | $226.5 | $226.72 | $133.65 | $158.43 |
| Long term investments | ||||
| Property, plant & equipment | $41.05 | $34.29 | $28.52 | $27.23 |
| Goodwill & intangible assets | $168.26 | $166.72 | $142.11 | $134.76 |
| Total noncurrent assets | $212.25 | $201.01 | $170.63 | $161.98 |
| Total investments | $49.25 | $109.3 | $45.9 | $55.48 |
| Total assets | $438.75 | $427.73 | $304.27 | $320.41 |
| Current liabilities | ||||
| Accounts payable | $12.65 | $11.15 | $9.32 | $10.04 |
| Deferred revenue | ||||
| Short long term debt | $10.3 | $7.96 | $13 | $12.36 |
| Total current liabilities | $41.67 | $30.87 | $29.71 | $35.03 |
| Long term debt | $13.46 | $0.76 | $15.22 | $13.83 |
| Total noncurrent liabilities | $20.05 | $18.21 | $49.19 | $50.62 |
| Total debt | $23.76 | $16.74 | $28.21 | $26.19 |
| Total liabilities | $61.72 | $49.08 | $78.91 | $85.64 |
| Shareholders' equity | ||||
| Retained earnings | -$197.74 | -$176.77 | -$178.03 | -$161.77 |
| Other shareholder equity | -$5.53 | -$5.4 | $8.49 | $7.91 |
| Total shareholder equity | $377.02 | $378.65 | $225.37 | $234.77 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $54.57 | $52.8 | $44.69 | $37.61 |
| Cost of revenue | $12 | $12.51 | $10.9 | |
| Gross Profit | $40.06 | $40.8 | $32.17 | $26.71 |
| Operating activities | ||||
| Research & development | $2.54 | $3 | $2.75 | |
| Selling, general & administrative | $43.92 | $38.9 | $32.03 | |
| Total operating expenses | $45.63 | $46.47 | $41.9 | $34.78 |
| Operating income | -$5.67 | -$9.72 | -$8.07 | |
| Income from continuing operations | ||||
| EBIT | -$5.79 | -$9.7 | -$7.21 | |
| Income tax expense | -$1.22 | -$0.02 | -$2.53 | -$0.21 |
| Interest expense | -$0.4 | $0.26 | $0.64 | -$0.3 |
| Net income | ||||
| Net income | -$7.92 | -$6.03 | -$7.8 | -$6.69 |
| Income (for common shares) | -$6.03 | -$7.8 | -$6.69 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $148.73 | $122.29 | $98.05 | $71.08 |
| Cost of revenue | $37.48 | $31.63 | $24.65 | $16.05 |
| Gross Profit | $111.25 | $90.66 | $73.4 | $55.03 |
| Operating activities | ||||
| Research & development | $10.2 | $8.01 | $5.54 | $5.27 |
| Selling, general & administrative | $126.82 | $104.44 | $85.73 | $70.17 |
| Total operating expenses | $138 | $117.86 | $90.34 | $81.77 |
| Operating income | -$26.75 | -$27.2 | -$16.94 | -$26.73 |
| Income from continuing operations | ||||
| EBIT | -$21.51 | -$1.26 | -$15.14 | -$30.25 |
| Income tax expense | -$0.34 | -$4.95 | -$1.13 | -$0.72 |
| Interest expense | -$0.2 | $2.42 | $2.25 | $3.41 |
| Net income | ||||
| Net income | -$20.97 | $1.26 | -$16.26 | -$32.94 |
| Income (for common shares) | -$20.97 | $1.26 | -$16.26 | -$32.94 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$6.03 | -$7.8 | -$6.69 | |
| Operating activities | ||||
| Depreciation | $4.78 | $5.03 | $5.19 | |
| Business acquisitions & disposals | -$20.69 | |||
| Stock-based compensation | $2.94 | $2.8 | $2.75 | |
| Total cash flows from operations | -$6.09 | -$6.69 | -$7.54 | |
| Investing activities | ||||
| Capital expenditures | -$6.68 | -$6.46 | -$3.84 | |
| Investments | $26.38 | $23.47 | $23.86 | |
| Total cash flows from investing | -$10.75 | $19.7 | -$3.68 | $17.92 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | -$0.77 | -$0.57 | $9.39 | |
| Total cash flows from financing | $53.68 | -$4.27 | -$0.57 | $9.39 |
| Effect of exchange rate | $0.15 | -$2.01 | $1.48 | $1.03 |
| Change in cash and equivalents | $20.02 | $7.33 | -$9.46 | $20.8 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$20.97 | $1.26 | -$16.26 | -$32.94 |
| Operating activities | ||||
| Depreciation | $17.39 | $13.1 | $10.68 | $8.01 |
| Business acquisitions & disposals | -$3.64 | -$40.09 | -$0.65 | -$4.19 |
| Stock-based compensation | $10.53 | $6.68 | $5.84 | $6.2 |
| Total cash flows from operations | -$27.05 | -$21.77 | -$13.06 | -$18.53 |
| Investing activities | ||||
| Capital expenditures | -$16.88 | -$10.03 | -$8.1 | -$10.5 |
| Investments | $64.3 | -$63.25 | $9.25 | -$55 |
| Total cash flows from investing | $41.68 | -$113.37 | -$7.41 | -$69.69 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.02 | $139.34 | $0.14 | $71.86 |
| Net borrowings | $9.28 | -$0.14 | -$0.13 | -$25.13 |
| Total cash flows from financing | $7.3 | $135.97 | $0.01 | $46.73 |
| Effect of exchange rate | $0.63 | $0.62 | -$0.66 | -$0.4 |
| Change in cash and equivalents | $22.57 | $1.46 | -$21.13 | -$41.9 |
News
Fundamentals
| Market cap | $517.94M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 24.21M |
| Revenue | $189.67M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$28.44M |
| Revenue Q/Q | 36.53% |
| Revenue Y/Y | 33.47% |
| P/E ratio | -18.21 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 2.73 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 2.11 |
| EPS | -$1.17 |
|---|---|
| ROA | -6.34% |
| ROE | N/A |
| Debt/Equity | 0.16 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 7.17 |
| Quick ratio | 3.68 |